Many people have heard about type 2 diabetes, but its common precursor, prediabetes, doesn’t get as much attention. Prediabetes affects about 88 million adults in the US, and an estimated 84% of people with prediabetes don’t know they have it. According to the CDC, 15-30% of these individuals will develop type 2 diabetes within five years. In other words, more than 26 million people that currently live with prediabetes could develop type 2 diabetes by 2026.
New to prediabetes? Check out “Starting Point: What Everyone Needs to Know about Prediabetes,” which answers some of the basics: what is prediabetes, what are its symptoms, how is it treated, and more.
For even more, see “Helpful Prediabetes Resources," with links to diaTribe articles focused on prediabetes, diet and nutrition, healthy lifestyle tips, and more.
COVID-19 cases are back on the rise. The best way to keep you, your loved ones, and those around you safe and healthy is to get vaccinated. Get our updates on the importance of vaccinations, especially for people with diabetes, COVID variants, vaccine boosters, and how to talk to others about vaccines. Continue Reading »
Nutritionist and educator Constance Brown-Riggs, MSEd, RDN, CDCES, CDN, discusses the relationship between food and heart health, and how you can make eating choices to prevent heart disease. Continue Reading »
Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2021 include changing standards of care, continuous glucose monitoring, and the latest in diabetes drug development. Continue Reading »
The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the largest conference in diabetes, including automated insulin delivery, continuous glucose monitoring, extremely promising drugs in development, and more. Continue Reading »
The latest innovations in diabetes technology have brought Time in Range (TIR) to the forefront of diabetes care. Read to learn about the most exciting TIR news from one of the biggest international diabetes conferences of the year, with a special focus on automated insulin delivery systems for kids, adults, and seniors. Continue Reading »
Wegovy, a once-weekly injectable medication (semaglutide), has been approved by the FDA to treat obesity and excess weight – conditions that can lead to type 2 diabetes and prediabetes. This new treatment has led to significant weight loss in clinical trials. Continue Reading »
New results show that Vida Health’s digital diabetes coaching program led to meaningful reductions in A1C levels among people with type 2 diabetes, especially for those highly engaged with the program. Continue Reading »
There are many things you can do to lower your risk of heart disease and stroke. One easy thing is to track the critical numbers that give you an accurate picture of your health – BMI & waist circumference, blood pressure, A1C, cholesterol, and kidney function. Continue Reading »
